EUDR for latex gloves and medical rubber manufacturers

Yes, if they are made from natural rubber latex. Surgical and examination gloves, catheters, tourniquets, dental dams and other finished products made from natural rubber (CN 4001) fall under the same Annex I entries as any other rubber article, and the business that first places them on the EU market is usually the one that owes the due diligence statement. Gloves made from nitrile, vinyl or other synthetic materials are not EUDR commodities at all, whatever the box says about being "medical grade".

Which rubber products are in scope

Natural rubber (CN 4001), including natural rubber latex under subheading 4001.10, is the commodity entry itself. Finished products made from it are listed separately under "ex" codes, meaning the heading is only in scope where the item is actually made from natural rubber rather than a synthetic rubber sharing the same tariff heading.

CN code	Product	In scope?
4001	Natural rubber, including latex	Yes — the commodity itself
ex 4015	Gloves, mittens and other rubber apparel, including medical and surgical gloves (subheading 4015.12)	Yes, if natural rubber
ex 4013	Inner tubes and similar tubing, including catheter and medical tubing applications	Yes, if natural rubber
ex 4007	Vulcanised rubber thread and cord, including elastic components	Yes, if natural rubber
ex 4017	Hard rubber (ebonite), used in some dental and laboratory equipment	Yes, if natural rubber
ex 4008	Plates, sheets, strip and profile shapes of vulcanised rubber	Yes, if natural rubber

Delegated Regulation (EU) 2026/2102, which took effect in September 2026, removed conveyor belts, a general catch-all for other vulcanised rubber articles, and most of the retreaded-tyre entry from Annex I. It did not touch the glove, tubing or thread entries. If you distribute finished latex gloves or medical rubber components, that removal does not change your position.

Natural rubber latex versus synthetic rubber

This is the detail that actually decides whether a glove is in scope, and it has nothing to do with whether the box is marked "medical", "surgical" or "examination". The EUDR regulates natural rubber as an agricultural commodity grown on cleared or retained forest land. It does not regulate synthetic rubber, which is a petrochemical product with no deforestation footprint.

Most disposable gloves sold today are nitrile — a synthetic copolymer of acrylonitrile and butadiene — not natural rubber latex. Nitrile gloves are classified under the same CN heading 4015 as latex gloves, because customs classification runs on the physical form of the product, not the raw material behind it. That means the CN code on an import declaration cannot tell you, by itself, whether a given consignment of gloves is an EUDR commodity. You have to know the compound.

Glove material	Composition	EUDR commodity?
Natural rubber latex	Hevea brasiliensis latex (CN 4001)	Yes
Nitrile	Synthetic acrylonitrile-butadiene rubber	No
Vinyl / PVC	Synthetic polymer	No
Neoprene	Synthetic polychloroprene	No
Blended or co-polymer gloves	Depends on actual natural rubber content	Only the natural rubber fraction

A manufacturer or importer that handles both latex and nitrile lines is running two different compliance tracks under one product category, and a customs broker filing on CN code alone will not catch the distinction. The practical fix is to have your supplier state the actual polymer on every commercial invoice and packing list, not just the tariff heading.

Who is the operator

The overwhelming majority of natural rubber latex gloves and medical rubber components sold in the EU are manufactured outside it — chiefly in Malaysia, and to a lesser extent Thailand, Indonesia and Vietnam — using latex tapped and processed locally. The raw latex itself rarely crosses into the EU; the finished glove or component does, typically under CN 4015 or 4013.

• The EU-based importer placing finished latex gloves, tubing or other rubber medical products on the EU market for the first time is the operator. It produces the due diligence statement, geolocation and risk assessment (unless simplified due diligence applies) and files in TRACES.
• A distributor or hospital supply wholesaler buying already-imported gloves within the EU and reselling them is downstream. Since Regulation (EU) 2025/2650, it does not file its own statement — it holds the reference number the importer obtained and keeps records of who it bought from and sold to.
• A non-EU glove manufacturer is not itself bound by the regulation, but cannot sell natural rubber latex products into the EU in practice without supplying the plantation-level geolocation its EU customer needs to file. A manufacturer unwilling to provide this is not a supplier an EU importer can keep buying from once its application date passes.
• An EU-based medical device manufacturer that imports raw latex and dips or moulds its own gloves domestically is the operator at that point of import, in the same way a tyre manufacturer importing raw rubber is.

Medical rubber products beyond gloves

Gloves draw the most attention because they are the highest-volume product, but the same test applies to anything else made from natural rubber latex: urinary and venous catheters, tourniquets, dental dams, elastic bandage components, anaesthesia bags and rubber vial stoppers all sit under the same "ex" tubing, thread or hard-rubber entries as a glove, if the compound is natural rather than synthetic. A manufacturer that assumes a product is out of scope because it is "a medical device, not a rubber product" is applying the wrong test. The regulation does not ask what the product is used for. It asks what it is made from.

This catches out component manufacturers more than finished-device makers. A business supplying natural rubber latex stoppers or tubing into a larger medical device assembly, without itself selling a finished device, is still placing an Annex I product on the EU market the first time that component crosses the border, and still needs to check whether it or its customer is the one filing.

EUDR and the Medical Device Regulation are separate regimes

Gloves and other items classed as medical devices under Regulation (EU) 2017/745 already carry CE marking, UDI (Unique Device Identification) traceability and, for sterile products, Notified Body oversight. None of that satisfies the EUDR. The two regimes trace different things for different reasons, and a product can be fully compliant with one while still missing the other entirely.

	Medical Device Regulation	EUDR
What it traces	The device, batch and manufacturing site, for safety and recall	The raw natural rubber, to plantation-level geolocation
Who it applies to	Manufacturers and importers of medical devices	Operators and traders handling Annex I commodities
Proof of compliance	CE mark, UDI, technical documentation	Due diligence statement filed in TRACES
Covers synthetic (nitrile, vinyl) gloves?	Yes	No

A hospital procurement team sourcing gloves on safety grounds alone can end up with a fully CE-marked, UDI-tracked product that has no due diligence statement behind it at all, if nobody downstream has checked which regime actually governs the raw material.

Where the latex actually comes from

Natural rubber latex glove manufacturing is far more geographically concentrated than natural rubber production generally. Country risk tiers under Implementing Regulation (EU) 2025/1093 vary across the main producers.

Country	Position in latex glove manufacturing	EUDR risk tier
Malaysia	Largest single producer and exporter of natural rubber gloves	Standard
Thailand	World's largest natural rubber grower; fast-growing glove manufacturing base	Low
Indonesia	Smaller glove manufacturing base, large raw rubber producer	Standard
Vietnam	Minor glove manufacturing, growing raw rubber producer	Low
China	Significant glove exporter, output weighted toward synthetic nitrile rather than natural latex	Standard

Malaysia sits in the standard-risk tier, which carries a full risk assessment and a 3% competent authority check rate rather than the simplified route. Malaysian industry bodies have pressed the Commission to reclassify the country as low risk at the next benchmarking review, but that has not happened as of this run. A consignment that mixes Malaysian and Thai latex is treated as standard risk throughout, because one standard-risk plot in the mix removes the simplified path for the whole shipment.

Deadlines

Your business	Deadline
Large or medium operator or trader	30 December 2026
Micro or small operator or trader	30 June 2027

Natural rubber was never an EU Timber Regulation product, so the earlier-deadline exception that pulls some micro and small timber businesses forward to the main date does not apply to glove or medical rubber businesses. The full deadline breakdown covers how operator size is calculated, including for a subsidiary of a larger group.

What to ask your supplier now

• Is this specific product line made from natural rubber latex, a synthetic polymer, or a blend — and in what proportion?
• If blended, what percentage by weight is natural rubber, and can that be confirmed on the commercial invoice rather than inferred from the CN code?
• Which plantations, smallholdings or latex collection centres supplied the natural rubber in this batch, and can you provide geolocation for them?
• Are you the business placing this product on the EU market for the first time, or has an earlier link in the chain already filed a due diligence statement whose reference number I should hold instead?
• Do you keep the records needed to answer these questions again for a repeat order in twelve months?

A supplier that cannot say whether a product is natural or synthetic rubber is not yet in a position to tell you whether it is an EUDR commodity at all, regardless of what safety certification it carries.

Check what the EUDR requires of your specific role in a latex glove or medical rubber supply chain, including whether your product mix of natural and synthetic materials splits your compliance obligations across two different tracks.